Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
https://www.zacks.com/stock/news/2263589/factors-setting-the-tone-for-lantheus-lnth-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2263589
Apr 26, 2024 - Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.
0
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2262802/compared-to-estimates-edwards-lifesciences-ew-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2262802
Apr 25, 2024 - Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
https://www.zacks.com/stock/news/2261581/watch-these-3-medtech-stocks-this-earnings-season-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2261581
Apr 24, 2024 - Here is a sneak peek into how the three major MedTech stocks, LH, EW and RMD, are expected to fare in their quarterly results slated to be released tomorrow.
0
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
https://www.zacks.com/stock/news/2259368/is-a-beat-likely-for-west-pharmaceutical-wst-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2259368
Apr 22, 2024 - West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
0
Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?
https://www.zacks.com/stock/news/2258737/will-acute-care-unit-aid-universal-health-s-uhs-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258737
Apr 19, 2024 - Universal Health's (UHS) Q1 results are expected to be aided by growing patient volumes and surgical cases, partly offset by increased expenses.
0
Will Humana (HUM) Q1 Earnings Beat on CenterWell Strength?
https://www.zacks.com/stock/news/2258552/will-humana-hum-q1-earnings-beat-on-centerwell-strength?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258552
Apr 19, 2024 - Humana's (HUM) first-quarter results are likely to reflect rising premiums and investment income.
0
Will Low Patient Days Impact Community Health (CYH) Q1 Earnings?
https://www.zacks.com/stock/news/2257857/will-low-patient-days-impact-community-health-cyh-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257857
Apr 18, 2024 - Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.
0
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
https://www.zacks.com/stock/news/2257849/bio-rad-laboratories-bio-to-post-q1-earnings-what-awaits?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257849
Apr 18, 2024 - The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
0
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://www.zacks.com/stock/news/2257726/edwards-lifesciences-ew-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2257726
Apr 18, 2024 - Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?
https://www.zacks.com/stock/news/2257013/is-a-beat-likely-for-edwards-lifesciences-ew-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257013
Apr 17, 2024 - The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.
0
Page 1>